- 全部删除
您的购物车当前为空
FY-21 是选择性 LSD1 抑制剂(IC50= 340 nM),抑制白血病细胞增殖和集落形成,降低转录因子 HOXA9 和 MEIS1 的 mRNA 水平,可用于研究白血病。


为众多的药物研发团队赋能,
让新药发现更简单!
FY-21 是选择性 LSD1 抑制剂(IC50= 340 nM),抑制白血病细胞增殖和集落形成,降低转录因子 HOXA9 和 MEIS1 的 mRNA 水平,可用于研究白血病。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 1,300 | In stock | |
| 2 mg | ¥ 1,920 | In stock | |
| 5 mg | ¥ 3,250 | In stock | |
| 10 mg | ¥ 4,750 | In stock | |
| 25 mg | ¥ 7,480 | In stock | |
| 50 mg | ¥ 9,870 | In stock | |
| 100 mg | ¥ 13,600 | In stock |
FY-21 相关产品
| 产品描述 | FY-21 is a selective LSD1 inhibitor (IC50= 340 nM) that inhibits proliferation and colony formation of leukemia cells, decreases mRNA levels of the transcription factors HOXA9 and MEIS1, and can be used in the study of leukemia. |
| 分子量 | 400.31 |
| 分子式 | C17H15F3N2O6 |
| Smiles | OC1=C(O)C=C(CCNC2C3=CC=C([N+]([O-])=O)C=C3)C2=C1.OC(C(F)(F)F)=O |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容